(Q46891969)

English

Angiographic and clinical outcomes of rosiglitazone in patients with type 2 diabetes mellitus after percutaneous coronary interventions: a single center experience

scientific article published in October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

Angiographic and clinical outcomes of rosiglitazone in patients with type 2 diabetes mellitus after percutaneous coronary interventions: a single center experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Ching-Chang Fang

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

Yeun Tarl Fresner Ng Jao

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

Yi-Chen

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

Ching-Lung Yu

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

Chi-Liang Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

Shih-Pu Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

publication date

1 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

58

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

523-534

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I)

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Insulin resistance, inflammation, and the prediabetic state

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Clinical studies on coronary revascularization in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Drug-eluting stents for diabetes mellitus: a rush to judgment?

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

1 reference

https://api.crossref.org/works/10.1177%2F0003319707303587

21 January 2018

Identifiers

10.1177/0003319707303587

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/18024934

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46891969&oldid=2136896741"